In new case study, CyPath Lung spares elderly woman from an invasive procedure for a suspicious lung nodule discovered on a ...
The FDA has cleared RevealDx’s AI-powered lung nodule risk assessment software, RevealAI-Lung, according to a company press ...
Lung cancer remains the leading cause of cancer-related mortality worldwide. Early detection of pulmonary nodules is crucial for timely diagnosis and ...
WTKR News 3 Norfolk, VA on MSN
Robotic technology helps doctors reach previously inaccessible lung nodules
None ...
News-Medical.Net on MSN
CNN-based system improves lung nodule detection and classification
Background and objectives Lung cancer remains the leading cause of cancer-related mortality worldwide. Early detection of pulmonary nodules is crucial for timely diagnosis and effective treatment.
THOMASVILLE — Archbold Pulmonology offers patients state-of-the-art technology with the Intuitive Ion robotic bronchoscopy ...
GlobalData on MSN
FDA clears Median Technologies’ lung nodule evaluation software
Median's eyonis LCS is software is reimbursable under Medicare at a rate between $601 to $700.
Medical Device Network on MSN
FDA clears RevealDX’s AI lung nodule diagnostic
RevealDX’s software analyses CT scans and assigns lung nodules with a Malignancy Similarity Index score to aid in lung cancer diagnosis.
Shira Boehler shares her journey being diagnosed with Stage 1 lung cancer. A doctor explains the need for better lung cancer screening for asymptomatic, never smokers.
Colon cancer survivor Vivian Chee has had three lung surgeries since 2021 but continues to keep fit. Read more at straitstimes.com. Read more at straitstimes.com.
Noninvasive CyPath® Lung test has shown 92% sensitivity, 87% specificity and 88% accuracy for detecting lung cancer in small nodules less than 2 centimetersCase study highlights how CyPath® Lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results